Estados financieros detallados de Evaxion Biotech A/S (EVAX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -116.0%, margen neto -115.5%.
Al precio actual de $3.03, EVAX presenta beneficios negativos (P/E no significativo) y un ROE del -45.23%. La capitalización bursátil es de $19M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $73000 | $3.3M | $7.5M |
| Coste de Ventas | $73928 | $80984 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$73928 | -$80984 | 0 | 0 | 0 | $73000 | $3.3M | $7.5M |
| I+D | $3.7M | $8.6M | $11.7M | $19.6M | $17.1M | $11.9M | $10.5M | $10.0M |
| Generales y Administrativos | $1.9M | $2.6M | $5.7M | $6.2M | $8.1M | $10.1M | $7.3M | $6.5M |
| Gastos Operativos | $5.6M | $11.3M | $16.6M | $25.8M | $25.3M | $22.3M | $18.1M | $16.8M |
| Beneficio Operativo | -$5.6M | -$11.4M | -$16.6M | -$25.8M | -$25.3M | -$22.2M | -$14.7M | -$9.2M |
| EBITDA | -$6.2M | -$11.9M | -$16.5M | -$24.2M | -$22.6M | -$21.4M | -$9.8M | -$7.1M |
| Gastos por Intereses | $698000 | $1.2M | $223000 | $915000 | $1.5M | $897000 | $962000 | $876000 |
| Beneficio Antes de Impuestos | -$6.3M | -$12.0M | -$16.6M | -$24.7M | -$23.9M | -$22.9M | -$11.4M | -$8.6M |
| Impuestos | -$735000 | -$824837 | -$1.6M | -$178000 | -$772000 | -$790000 | -$788000 | -$908000 |
| Beneficio Neto | -$5.5M | -$11.2M | -$15.0M | -$24.5M | -$23.2M | -$22.1M | -$10.6M | -$7.7M |
| BPA | $-11.52 | $-27.60 | $-37.00 | $-50.40 | $-39.20 | $-32.40 | $-9.80 | $-1.21 |
| BPA Diluido | $-11.52 | $-27.60 | $-37.00 | $-50.40 | $-39.20 | $-32.40 | $-9.80 | $-1.21 |
| Acciones en Circulación (Diluidas) | $479966 | $404966 | $404966 | $487328 | $590967 | $683395 | $1.1M | $6.4M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $468000 | $7.4M | $9.6M | $5.8M | $32.2M | $13.2M | $5.6M | $5.1M | $23.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $2.1M | $772000 | 0 | 0 | 0 | 0 | 0 | $1.9M | $1.1M |
| Inventario | 0 | -$1.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.7M | $8.4M | $11.0M | $10.9M | $34.7M | $17.0M | $8.3M | $8.8M | $24.9M |
| Inmovilizado Material | $213000 | $130000 | $101000 | $221000 | $5.2M | $4.7M | $4.3M | $3.5M | $3.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $100000 | $93000 | 0 | 0 | 0 | 0 |
| Activos Totales | $2.9M | $8.5M | $11.1M | $12.0M | $40.2M | $22.0M | $12.9M | $12.5M | $28.4M |
| Cuentas por Pagar | $59000 | $139000 | $646000 | $3.7M | $2.8M | $2.1M | $2.7M | $3.0M | $2.2M |
| Deuda a Corto | 0 | $8.6M | 0 | 0 | $126000 | $136000 | $159000 | $159000 | $190000 |
| Pasivos Corrientes | $303000 | $9.4M | $1.7M | $4.9M | $4.3M | $3.8M | $7.1M | $4.4M | $4.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $1.0M | $7.9M | $8.5M | $8.0M | $5.3M |
| Pasivos Totales | $399000 | $9.4M | $1.7M | $4.9M | $7.7M | $13.7M | $17.6M | $14.1M | $11.4M |
| Reservas | -$3.5M | -$7.0M | -$15.8M | -$27.3M | -$50.4M | -$85.8M | -$108.0M | -$118.5M | -$126.2M |
| Patrimonio Neto | $2.5M | -$931000 | $9.4M | $7.0M | $32.4M | $8.3M | -$4.7M | -$1.7M | $17.0M |
| Deuda Total | $162000 | $8.7M | $36000 | $20000 | $3.7M | $10.3M | $10.9M | $10.1M | $7.5M |
| Deuda Neta | -$306000 | $1.2M | -$9.5M | -$5.8M | -$28.5M | -$2.9M | $5.3M | $5.0M | -$15.7M |
| Capital Circulante | $2.4M | -$1.0M | $9.2M | $6.0M | $30.4M | $13.2M | $1.3M | $4.4M | $20.6M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$5.5M | -$11.2M | -$15.0M | -$24.5M | -$23.2M | -$22.1M | -$10.6M | -$7.7M |
| Amortizaciones | $74000 | $81000 | $105000 | $344000 | $571000 | $615000 | $607000 | $616882 |
| Compensación en Acciones | $2.1M | $2.4M | $3.4M | $1.4M | $942000 | $479000 | $357000 | 0 |
| Cambio en Capital Circulante | $981000 | $573000 | $215000 | $1.2M | -$2.9M | $1.6M | $520000 | -$137419 |
| Flujo de Caja Operativo | -$2.0M | -$7.0M | -$12.4M | -$21.9M | -$25.8M | -$17.7M | -$12.9M | -$6.6M |
| Inversiones (CapEx) | -$7000 | -$68000 | -$393000 | -$1.4M | -$292000 | -$87000 | 0 | -$11034 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | -$13000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$2.0M | -$7.1M | -$12.8M | -$23.3M | -$26.1M | -$17.8M | -$12.9M | -$6.7M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +4480.8% | +125.1% | ||||||
| Crecimiento Beneficio Neto (anual) | -102.2% | -34.2% | -63.4% | +5.6% | +4.5% | +52.2% | +27.1% | |
| Crecimiento BPA (anual) | -139.6% | -34.1% | -36.2% | +22.2% | +17.3% | +69.8% | +87.7% | |
| Cambio en Acciones (anual) | -15.6% | +0.0% | +20.3% | +21.3% | +15.6% | +57.0% | +497.3% | |
| Crecimiento FCF (anual) | -254.7% | -81.0% | -81.5% | -11.9% | +31.8% | +27.2% | +48.6% | |
| Margen Bruto | 100.0% | 100.0% | 100.0% | |||||
| Margen Operativo | -30406.8% | -440.6% | -122.7% | |||||
| Margen EBITDA | -29319.2% | -292.6% | -94.6% | |||||
| Margen Neto | -30308.2% | -316.0% | -102.4% | |||||
| Margen FCF | -24353.4% | -387.0% | -88.4% | |||||
| Tasa Impositiva Efectiva | 11.7% | 6.9% | 9.4% | 0.7% | 3.2% | 3.4% | 6.9% | 10.5% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-4.16 | $-17.50 | $-31.68 | $-47.80 | $-44.11 | $-26.01 | $-12.06 | $-1.04 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $479966 | $404966 | $404966 | $487328 | $590967 | $683395 | $1.1M | $6.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -45.23% |
| Rentabilidad sobre capital invertido | -33.44% |
| Rentabilidad sobre activos | -27.13% |
| Margen bruto | 100.00% |
| Margen operativo | -115.98% |
| Margen neto | -115.49% |
Salud financiera
| Deuda / Patrimonio | 0.75 |
| Ratio corriente | 5.06 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -4.54 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| P/E | 0.00 | -42.93 | -17.92 | -13.36 | -4.38 | -2.26 | -1.06 | -0.43 | -3.94 |
| P/VC | 0.00 | -254.93 | 21.39 | 28.45 | 3.32 | 6.32 | -4.95 | -2.75 | 1.79 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 320.92 | 1.36 | 4.06 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 100.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -30406.8% | -440.6% | -122.7% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -30308.2% | -316.0% | -102.4% |
Empresas relacionadas: ANVS · BCAB · BTAI · CELU · GBIO · MURA · PYPD
Explorar sector: Healthcare · Biotechnology
Más secciones de EVAX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones